![Comparison of clinical outcomes of edoxaban versus apixaban, dabigatran, rivaroxaban, and vitamin K antagonists in patients with atrial fibrillation in Germany: A real-world cohort study - International Journal of Cardiology Comparison of clinical outcomes of edoxaban versus apixaban, dabigatran, rivaroxaban, and vitamin K antagonists in patients with atrial fibrillation in Germany: A real-world cohort study - International Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/8629aa60-4bf9-464f-83af-f1c0285432e4/gr1.jpg)
Comparison of clinical outcomes of edoxaban versus apixaban, dabigatran, rivaroxaban, and vitamin K antagonists in patients with atrial fibrillation in Germany: A real-world cohort study - International Journal of Cardiology
![Design and rationale of the STroke secondary prevention with catheter ABLation and EDoxaban clinical trial in patients with non-valvular atrial fibrillation: The STABLED study - ScienceDirect Design and rationale of the STroke secondary prevention with catheter ABLation and EDoxaban clinical trial in patients with non-valvular atrial fibrillation: The STABLED study - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0914508719301728-gr1.jpg)
Design and rationale of the STroke secondary prevention with catheter ABLation and EDoxaban clinical trial in patients with non-valvular atrial fibrillation: The STABLED study - ScienceDirect
![Edoxaban Versus Warfarin Stratified by Average Blood Pressure in 19 679 Patients With Atrial Fibrillation and a History of Hypertension in the ENGAGE AF-TIMI 48 Trial | Hypertension Edoxaban Versus Warfarin Stratified by Average Blood Pressure in 19 679 Patients With Atrial Fibrillation and a History of Hypertension in the ENGAGE AF-TIMI 48 Trial | Hypertension](https://www.ahajournals.org/cms/asset/22b97e43-c655-4097-bb81-150d156d5272/597ga1.jpg)
Edoxaban Versus Warfarin Stratified by Average Blood Pressure in 19 679 Patients With Atrial Fibrillation and a History of Hypertension in the ENGAGE AF-TIMI 48 Trial | Hypertension
![Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial - The Lancet Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2069221902/2067612249/gr1.gif)
Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial - The Lancet
![Efficacy and safety of edoxaban in patients with diabetes mellitus in the ENGAGE AF-TIMI 48 trial - International Journal of Cardiology Efficacy and safety of edoxaban in patients with diabetes mellitus in the ENGAGE AF-TIMI 48 trial - International Journal of Cardiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/8d556d20-98a1-4af4-bbd4-2740659ef278/gr1_lrg.jpg)
Efficacy and safety of edoxaban in patients with diabetes mellitus in the ENGAGE AF-TIMI 48 trial - International Journal of Cardiology
![Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver Disease - ScienceDirect Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver Disease - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0735109719352283-fx1.jpg)
Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver Disease - ScienceDirect
![Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver Disease | Journal of the American College of Cardiology Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver Disease | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/ce1d741f-6a97-4d25-a617-8b33d22a40e6/fx1.jpg)
Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver Disease | Journal of the American College of Cardiology
![Edoxaban May Be Effective Treatment for Atrial Fibrillation After Transcatheter Aortic Valve Replacement | Mount Sinai - New York Edoxaban May Be Effective Treatment for Atrial Fibrillation After Transcatheter Aortic Valve Replacement | Mount Sinai - New York](https://www.mountsinai.org/files/MSHealth/Assets/Global/Newsroom/2021/MSHS-Newsroom-StudyDesign-2col-770x420.jpg)